Skip to main content
. 2022 Dec 13;27(5):1461–1476. doi: 10.1177/13623613221140749

Table 2.

Participant characteristics.

Characteristics NeuroACT (n = 20) TAU (n = 19) Total (N = 39)
n n n
Gender, male 10 11 21
Age (years) M
38.4
(SD)
(10.0)
M
39.8
(SD)
(14.4)
M
39.1
(SD)
(12.2)
Psychiatric comorbidity
 ADHD/ADD 9 6 15
 Depression, depressive episode NOS, dysthymia 4 5 9
 Anxiety disorders 5 0 5
 Other comorbidities (e.g. dyslexia; bipolarity) 5 3 8
 Any psychiatric comorbidity 11 11 22
Medication
 Antihistamines 2 7 9
 Sleep medication 4 5 9
 Antidepressants 5 8 13
 Methylphenidate 5 7 12
 Other medication 6 11 17
 Any medication 13 16 29
Education
 University/higher education 7 3 10
 High school 9 12 21
 Elementary school 3 3 6
 Other 1 1 2
Occupation
 Company owner/employee/student/parental leave 7 5 12
 Part-time employee/temporary position 2 3 5
 Pensioner 0 1 1
 Unemployed 2 4 6
 Temporary disability pension/early retirement benefit 5 3 8
 Other 4 3 7

ACT: acceptance and commitment therapy; TAU: treatment as usual; ADHD: attention deficit hyperactivity disorder; ADD: attention deficit disorder; NOS: not otherwise specified.